Full List Of Stories
Sunday share tips: N Brown Group, Foxtons
The Financial Mail on Sunday's Midas column touted a raft of shares which it expected would benefit from the fight against obesity as well as the associated, and sometimes fatal, health risks.
WHO warns of potential 'catastrophic moral failure' in vaccine rollouts
The head of the World Health Organisation called for what he said would be a more equitable distribution of Covid-19 vaccines globally, warning that it was more important than ever given the appearance of new strains of the novel coronavirus.
Tuesday preview: Goldman Sachs, Bank of America, Centamin in focus
The market spotlight on Tuesday will fall on US banking heavyweights Bank of America and Goldman Sachs, as they release their fourth quarter earnings.
FTSE 250 movers: Genus boosted by China, Chemring wanted as Cyber Security play
London's second-tier index was trading slightly higher at the start of the week, with risk appetite buoyed by what little macroeconomic data was available given that Wall Street was closed in observance of the Martin Luther King Jr. holiday.
FTSE 100 movers: Defensives slip, Banks wanted
The top-flight index was trading slightly lower in later afternoon trading, weighed down slightly by interest rate sensitive and defensive stocks such as BT Group, United Utilities and Hikma Pharmaceuticals.
Sunday newspaper round-up: New Covid strains, Lockdown measures, Google
Britain will be able to vaccinate the entire nation against dangerous new Covid strains within four months after a £158m super-factory opens later this year, The Telegraph can disclose. Dr Matthew Duchars, chief executive of the Vaccines Manufacturing Innovation Centre (VMIC), revealed the Oxfordshire facility will be capable of producing 70m doses of an emergency vaccine manufactured entirely on British soil. - Sunday Telegraph.